Printer Friendly

SENETEK RECEIVES COMMITMENT FOR FINANCING

 SENETEK RECEIVES COMMITMENT FOR FINANCING
 ST. LOUIS, Feb. 12 /PRNewswire/ -- "Senetek Plc has received a


commitment for a $5.6 million financing, of which at least $3.6 million will be equity with the balance in the form of a loan or additional equity," Dr. Gerlof Homan, president and CEO, announced today.
 Consummation is subject to customary conditions of closing, Dr. Homan further stated.
 -0- 2/12/92
 /CONTACT: Dr. Gerlof Homan, president and CEO of Senetek, 314-542-2202/
 (SNTYC) CO: Senetek Plc ST: Missouri IN: SU: FNC


BR-BN -- AT003 -- 9201 02/12/92 11:29 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 12, 1992
Words:96
Previous Article:LEGGETT & PLATT DECLARES FIRST QUARTER DIVIDEND
Next Article:MEDIQ SUBSIDIARY, PCI SERVICES, INC., SELLS ADDITIONAL SHARES OF COMMON STOCK


Related Articles
SENETEK PLC ANNOUNCES APPROVAL TO BEGIN FORMAL CLINICAL TRIALS OF MALE SEXUAL DYSFUNCTION PRODUCT
SENETEK PRESIDENT ISSUES STATEMENT ON COMPANY'S PROGRESS
SENETEK RECEIVES NOTICE FROM ORTHO PHARMACEUTICAL
SENETEK TO ADVANCE TIME SCHEDULE FOR MARKETING MALE SEXUAL DYSFUNCTION PRODUCT
SENETEK PLC TO ACQUIRE ASSETS OF CARME, INC. FOR ABOUT $4 MILLION
Senetek Reports Third-Quarter and Nine-Month Results
Senetek PLC's Chief Scientist Purchases 200,000 Shares of SNTKY Common Stock
Senetek Files Third Product Licensing Application (PLA); Seeks Approval To Market Its INVICORP Therapy for Erectile Dysfunction in Ireland
Senetek PLC Reports Second-Quarter and Six-Month 1997 Financial Results
Senetek strengthens skincare and dermatological pipeline by agreement Athens University.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters